3
Announcements
Trials
Browse
Landscape
Phase
Phase 1/2
2
Phase NA
1
Phase 2
1
Status
Completed
2
Terminated
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Lymphoid
1
Conditions
Breast Neoplasms
192
Neoplasms
148
Prostatic Neoplasms
101
Lung Neoplasms
90
Carcinoma, Non-Small-Cell Lung
62
Colorectal Neoplasms
59
Head and Neck Neoplasms
52
Pancreatic Neoplasms
46
Carcinoma, Hepatocellular
44
Rectal Neoplasms
42
Brain Neoplasms
41
Multiple Myeloma
40
Colonic Neoplasms
37
Esophageal Neoplasms
34
Precursor Cell Lymphoblastic Leukemia-Lymphoma
31
Neoplasm Metastasis
30
Leukemia, Myeloid, Acute
30
Ovarian Neoplasms
29
Lymphoma, Non-Hodgkin
29
Leukemia
29
Lymphoma
28
Motor Activity
26
Hodgkin Disease
24
Uterine Cervical Neoplasms
23
Carcinoma, Renal Cell
23
Pain
22
Lymphoma, Follicular
22
Depression
22
Leukemia, Lymphocytic, Chronic, B-Cell
21
Glioma
21
Interventions
fludarabine phosphate
1
fludarabine
1
Mesna
1
Cyclophosphamide
1
Busulfan
1
Alemtuzumab
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Phase NA
×
Terminated
×
Thalassemia
×
Clear all
NCT00578292
2020-05-01
THALLO
Baylor College of Medicine
Phase NA
Terminated
10 enrolled
15 charts